Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Apyx Medical Corporation

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2022 Financial Results on November 10, 2022
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022
From Apyx Medical Corporation
Via Business Wire
Tickers APYX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.